Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats
<p>Abstract</p> <p>Background</p> <p>Avascular necrosis of bone (osteonecrosis) can cause structural failure and subsequent deformation, leading to joint dysfunction and pain. Structural failure is the result of resorption of necrotic bone during revascularization, befo...
Main Authors: | Aspenberg Per, Åstrand Jörgen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2002-08-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/3/19 |
Similar Items
-
Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats
by: Aspenberg Per, et al.
Published: (2006-08-01) -
Combined Pharmacotherapy with Alendronate and Desferoxamine Regulate the Bone Resorption and Bone Regeneration for Preventing Glucocorticoids-Induced Osteonecrosis of the Femoral Head
by: Hongfeng Sheng, et al.
Published: (2020-01-01) -
Morphological and histomorphometric evaluation of autogenous bone graft resorption in rabbits treated with alendronate sodium
by: Teo Mario da ROSA, et al. -
Impregnation of bone chips with alendronate and cefazolin, combined with demineralized bone matrix: a bone chamber study in goats
by: Mathijssen Nina MC, et al.
Published: (2012-03-01) -
Anti-resorptive effect of Sodium Alendronate and the combination of Alendronate and Atorvastatin in ligature-induced periodontitis in rats. PAULA
by: Paula GÃes Pinheiro Dutra
Published: (2012)